ETF MANAGERS GROUP, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q1 2023$213,093
+83.7%
8,890
+13.3%
0.01%
+75.0%
Q3 2022$116,000
-10.1%
7,843
-6.0%
0.00%0.0%
Q2 2022$129,000
-41.4%
8,347
+4.3%
0.00%0.0%
Q1 2022$220,000
-29.0%
8,000
+0.4%
0.00%
-33.3%
Q4 2021$310,000
-27.2%
7,969
-12.6%
0.01%
-25.0%
Q3 2021$426,000
+59.0%
9,119
+17.5%
0.01%
+100.0%
Q2 2021$268,000
-61.2%
7,763
-56.4%
0.00%
-66.7%
Q1 2021$691,000
+24.3%
17,821
+49.6%
0.01%0.0%
Q4 2020$556,000
-4.8%
11,913
-12.8%
0.01%
-36.8%
Q3 2020$584,000
+86.6%
13,668
+105.2%
0.02%
+72.7%
Q2 2020$313,0006,6600.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders